Cancer stem cells: A contentious hypothesis now moving forward.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 24333726)

Published in Cancer Lett on December 11, 2013

Authors

Michael L O'Connor1, Dongxi Xiang1, Sarah Shigdar1, Joanna Macdonald1, Yong Li2, Tao Wang1, Chunwen Pu3, Zhidong Wang3, Liang Qiao4, Wei Duan5

Author Affiliations

1: School of Medicine, Deakin University, Pigdons Road, Waurn Ponds, Victoria 3217, Australia.
2: Cancer Care Centre, St. George Hospital, and St. George Clinical School, Faculty of Medicine, University of New South Wales, Kensington, NSW 2052, Australia.
3: Dalian Sixth People's Hospital, Dalian 116033, China.
4: Storr Liver Unit, Westmead Millennium Institute, The University of Sydney at the Westmead Hospital, Westmead, NSW 2145, Australia. Electronic address: liang.qiao@sydney.edu.au.
5: School of Medicine, Deakin University, Pigdons Road, Waurn Ponds, Victoria 3217, Australia. Electronic address: wduan@deakin.edu.au.

Associated clinical trials:

PTC596 in Patients With Advanced Solid Tumors | NCT02404480

Articles citing this

Prognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysis. Int J Clin Exp Med (2015) 0.96

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol (2016) 0.96

Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis. Biores Open Access (2015) 0.91

Small nucleolar RNA signatures of lung tumor-initiating cells. Mol Cancer (2014) 0.88

Gastric cancer stem cells: evidence, potential markers, and clinical implications. J Gastroenterol (2015) 0.87

Notch signaling in serous ovarian cancer. J Ovarian Res (2014) 0.87

Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine. Theranostics (2015) 0.87

In vitro enrichment of ovarian cancer tumor-initiating cells. J Vis Exp (2015) 0.86

Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro. J Anat (2014) 0.84

Characterization of Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma. Front Surg (2016) 0.84

Phenotypic diversity of patient-derived melanoma populations in stem cell medium. Lab Invest (2015) 0.84

CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis. Oncotarget (2016) 0.84

Common stemness regulators of embryonic and cancer stem cells. World J Stem Cells (2015) 0.84

Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma. J Radiat Res (2016) 0.84

Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy. Chin J Cancer (2015) 0.82

Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer. J Cell Commun Signal (2015) 0.82

Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump. J Med Chem (2014) 0.81

Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors. Theranostics (2015) 0.81

The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications. Oncotarget (2016) 0.81

Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX. Theranostics (2016) 0.80

The LIN28/let-7 Pathway in Cancer. Front Genet (2017) 0.79

A short update on cancer chemoresistance. Wien Med Wochenschr (2014) 0.79

Just like the rest of evolution in Mother Nature, the evolution of cancers may be driven by natural selection, and not by haphazard mutations. Oncoscience (2014) 0.79

In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. BMC Cancer (2015) 0.79

Targeting lung cancer through inhibition of checkpoint kinases. Front Genet (2015) 0.79

Molecular pathways involved in pregnancy-induced prevention against breast cancer. Front Endocrinol (Lausanne) (2014) 0.78

Anaplastic Thyroid Carcinoma: A ceRNA Analysis Pointed to a Crosstalk between SOX2, TP53, and microRNA Biogenesis. Int J Endocrinol (2015) 0.78

The role of purinergic receptors in stem cell differentiation. Comput Struct Biotechnol J (2014) 0.78

A peculiar mutation spectrum emerging from young peruvian patients with hepatocellular carcinoma. PLoS One (2014) 0.78

CD44, Sonic Hedgehog, and Gli1 Expression Are Prognostic Biomarkers in Gastric Cancer Patients after Radical Resection. Gastroenterol Res Pract (2015) 0.78

SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer. BMC Cancer (2016) 0.77

Differentiation resistance through altered retinoblastoma protein function in acute lymphoblastic leukemia: in silico modeling of the deregulations in the G1/S restriction point pathway. BMC Syst Biol (2016) 0.77

In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays. Oncotarget (2016) 0.77

FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations. Cancer Sci (2016) 0.76

The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells. Stem Cells Int (2016) 0.76

Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor. Oncol Lett (2016) 0.75

Management of relapsed ovarian cancer: a review. Springerplus (2016) 0.75

Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System. Front Surg (2016) 0.75

The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol Cancer (2017) 0.75

Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells. Cell Mol Gastroenterol Hepatol (2017) 0.75

Anti-Cancer Phytometabolites Targeting Cancer Stem Cells. Curr Genomics (2017) 0.75

Cancer stem cells as a potential therapeutic target in breast cancer. Stem Cell Investig (2014) 0.75

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies. BMC Cancer (2017) 0.75

Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review. World J Gastrointest Pathophysiol (2016) 0.75

Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation. J Transl Med (2016) 0.75

Identification of therapeutic targets applicable to clinical strategies in ovarian cancer. BMC Cancer (2016) 0.75

Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer. Transl Oncol (2017) 0.75

The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular Mechanisms. Nutrients (2016) 0.75

Comparison of leucine-rich repeat-containing G protein-coupled receptor 5 expression in different cancer and normal cell lines. Biomed Rep (2016) 0.75

Feedback Regulation in a Cancer Stem Cell Model can Cause an Allee Effect. Bull Math Biol (2016) 0.75

Cancer Stem Cells: Plasticity Works against Therapy. Acta Naturae (2016) 0.75

Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells. Sci Rep (2017) 0.75